SkinnyRx vs Willow: Oral semaglutide and care compared
Choosing between SkinnyRx and Willow comes down to treatment format and support model. SkinnyRx focuses on compounded daily oral semaglutide tablets with financial options and fast shipping, while Willow emphasizes a telehealth-first program with progress tracking and follow-up consultations. Early verdict: pick SkinnyRx if you prioritize FSA/HSA eligibility, free overnight shipping, and oral semaglutide tablets; choose Willow if you want structured digital follow-up alongside oral GLP-1 care.
Explore SkinnyRx oral semaglutide from $249/mo
How SkinnyRx and Willow differ at a glance
Both providers offer oral GLP-1 care delivered through online consultations and licensed clinicians, but the evidence highlights key differences in price entry, shipping and payment flexibility, program structure, and how compounded medications are presented.
| Criteria | SkinnyRx | Willow |
|---|---|---|
| Starting price | As low as $249/mo | $299 |
| Product format highlighted | Daily oral semaglutide tablets, taken sublingually | Oral GLP-1 program (details not captured) |
| Financial options | FSA/HSA eligible; Affirm Buy Now Pay Later noted | Not supplied |
| Support emphasis | Personalized care, ongoing support, patient care team | Progress tracking tools and follow-up consultations |
| Shipping | Free overnight shipping on all orders; tracking within 2 business days | Not verified on captured page |
| Compounded medication note | Compounded semaglutide available; not FDA-approved for weight loss; partner pharmacies test every 3 to 6 months | Compounded medications, when offered, are not FDA-approved |
Price, payment, and shipping: direct contrast
SkinnyRx lists a clear entry price of as low as $249/mo and explicitly mentions FSA/HSA eligibility and Affirm financing. It also advertises free overnight shipping and shipping notifications within 2 business days after prescription processing. Willow shows a $299 entry price in captured evidence but the landing page was not fully readable and shipping or payment details were not verified on the captured page.
See Willow program and tracking features
Program structure and patient support compared
SkinnyRx describes a personalized care model with licensed providers who tailor treatment, ongoing support, and a patient care team available for questions. It frames its offering as clinician-guided treatment with refill forms at month end and the ability to cancel before a provider completes a prescription review for a full refund. Willow presents a telehealth-first weight management program that emphasizes progress tracking, follow-up consultations, and a structured journey to convert medication effects into sustainable outcomes. Willow is positioned for users who want behavioral scaffolding in addition to medication.
Compounded medication and regulatory notes
Both providers include regulatory qualifiers for compounded medications. SkinnyRx states that compounded semaglutide is not FDA-approved and that partner pharmacies run third-party testing through FDA- and DEA-compliant labs every 3 to 6 months, confirming concentration within plus or minus 10 percent. The source for Willow notes that compounded medications, when offered, are not FDA-approved and that medication-specific approval status must be confirmed. These statements preserve the captured regulatory limitations and testing claims.
View SkinnyRx testing and regulatory details
Outcomes, claims, and evidence captured
SkinnyRx included benefit statements such as losing up to 8.6 lbs in the first month and patient testimonials like 37 lbs lost in 5 months; it also references third-party study benefits for semaglutide on blood sugar control and cardiovascular risk reduction for certain populations. Willow’s captured evidence focuses on the support infrastructure and does not include specific outcome numbers in the readable capture. Neither provider’s material changes the underlying regulatory note that compounded drugs are not FDA-approved or evaluated by the FDA.
Start an online consultation with SkinnyRx
Final comparison and who should choose which
SkinnyRx vs Willow breaks down into two priorities: medication access and financial/shipping features versus program structure and behavioral support. SkinnyRx is centered on oral semaglutide tablets with clear pricing from as low as $249/mo, FSA/HSA eligibility, and free overnight shipping plus partner pharmacy testing details. Willow centers its value on licensed telehealth follow-up, progress tracking, and a structured weight management journey, with a captured price of $299 but limited captured shipping or payment details.
Choose SkinnyRx if you want oral semaglutide with FSA/HSA flexibility, fast free overnight shipping, and clinician-guided refill routines. Choose Willow if you want a telehealth-first program with progress tracking and structured follow-up support.
Primary keyword: SkinnyRx vs Willow